Missed opportunities for HIV diagnosis among those at risk

June 27, 2018

(HealthDay)—Considerable numbers of men who have sex with men (MSM) and persons who inject drugs (PWID) who are unaware of their HIV infection report missed opportunities for diagnosis, according to a research letter published online June 26 in the Journal of the American Medical Association.

Cyprian Wejnert, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the percentages of MSM and PWID who were unaware of their HIV infection and had missed opportunities for testing and diagnosis in clinical settings. Data were included for 9,105 MSM and 19,357 PWID.

The researchers found that 22 percent of MSM and 8 percent of PWID had a positive result for HIV infection. Of the participants who were HIV positive, 8 and 12 percent, respectively, were unaware of their infection. Among those who were unaware, 81 percent of MSM and 65 percent of PWID reported having visited a clinician in the past year. In that time, 43 and 24 percent, respectively, reported being offered an HIV test. Overall, 44 percent of unaware MSM and 77 percent of unaware PWID reported not being tested for HIV test in the past year; 52 and 45 percent of those not tested in the past year reported not having been offered an HIV test at a clinic visit.

"Eliminating missed opportunities for HIV testing and diagnosis in health care settings may reduce HIV transmission, especially among high-risk groups," the authors write.

Explore further: New perspectives on risk of HIV and hepatitis among injecting drug users

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

New perspectives on risk of HIV and hepatitis among injecting drug users

October 24, 2017
Reviews of the global prevalence of injecting drug use and of interventions to prevent the spread of blood-borne viruses among people who inject drugs paint a worrying picture.

Cutting HIV in drug users can benefit others' AIDS mortality

March 26, 2014
(HealthDay)—Efforts to curb HIV transmission among people who inject drugs (PWID) and non-injecting drug users (NIDUs) may reduce AIDS and AIDS-related mortality among heterosexuals, according to a study published in the ...

Emerging HIV epidemics among people who inject drugs in the Middle East and North Africa

June 19, 2014
HIV epidemics are emerging among people who inject drugs in several countries in the Middle East and North Africa. Though HIV infection levels were historically very low in the Middle East and North Africa, substantial levels ...

Researchers examine the relationship between drug injection risk behaviors and immune activation

April 13, 2017
The use of heroin and other illicit drugs has been shown to trigger a response from the body's immune system. Consequently, high levels of immune activation (inflammation)—that is associated with the progression of chronic ...

Severe liver damage in mid/late-adulthood among PWID with chronic HCV

October 5, 2015
The Hepatitis C virus (HCV) infection is a chronic blood-borne viral infection that affects an estimated 160 million people, or 2-3% of the population world-wide. Alarmingly, chronic HCV infection accounts for one-quarter ...

Lack of recent health care tied to unawareness of diabetes

March 21, 2017
(HealthDay)—Factors that are associated with being unaware of diabetes include not receiving health care in the past year, while a family history of diabetes and hospitalizations in the past year are factors associated ...

Recommended for you

Study shows how HIV is shielded from immune attack

July 10, 2018
Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being destroyed by the host's immune system.

Out-of-pocket costs put HIV prevention drug out of reach for many at risk

July 4, 2018
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks—the drug's price tag, which ...

New simulation tool predicts how well HIV-prophylaxis will work

June 14, 2018
A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal ...

Many at risk for HIV despite lifesaving pill

June 11, 2018
Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

Active HIV in large white blood cells may drive cognitive impairment in infected mice

June 7, 2018
Macrophages, large white blood cells that engulf and destroy potential pathogens, harbor active viral reserves that appear to play a key role in impaired learning and memory in mice infected with a rodent version of HIV. ...

HIV vaccine elicits antibodies in animals that neutralize dozens of HIV strains

June 4, 2018
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world. The findings were reported ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.